Patents by Inventor Allen D. Allen

Allen D. Allen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
    Patent number: 6534057
    Abstract: Methods for treating and inhibiting disease and symptoms associated with the human immunodeficiency virus (HIV) are provided. The method includes transforming the human immunodeficiency virus (HIV) infection into a nonserious disease through the infusion of monoclonal antibodies directed against particular antigens on anti-self, anti-CD4 cytotoxic T-lymphocytes. The monoclonal antibodies are primarily directed against the alpha or beta chain of LFA-1.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: March 18, 2003
    Inventor: Allen D. Allen
  • TREATMENT OF IMMUNE SUPPRESSION BY INFUSING A DOSE OF SELECTED MONOCLONAL ANTIBODIES THAT INHIBIT OVERPRODUCTION OF LYMPHOCYTE FUNCTION-RELATED ANTIGEN 1 (LFA-1) ON CD8CELLS
    Publication number: 20010006638
    Abstract: Methods for treating and inhibiting disease and symptoms associated with the human immunodeficiency virus (HIV) are provided. The method includes transforming the human immunodeficiency virus (HIV) infection into a nonserious disease through the infusion of monoclonal antibodies directed against particular antigens on anti-self, anti-CD4 cytotoxic T-lymphocytes. The monoclonal antibodies are primarily directed against the alpha or beta chain of LFA-1.
    Type: Application
    Filed: September 30, 1997
    Publication date: July 5, 2001
    Inventor: ALLEN D. ALLEN
  • Method for measuring retarded light through very long baseline interferometry and natural or artifical diffraction effects
    Patent number: 5847830
    Abstract: Methods are provided for measuring retarded light that takes longer than x/c time to travel through a vacuum to a detector x distance from the source. The method exploits the frame invariance of in vacuo light speed c and the quantum mechanical nature of photons. It includes placing instrumentation packages consisting of detectors, broadband recording devices and atomic clocks at large distances from each other and from the source of an electromagnetic signal, such that the detectors are located at the extreme sidebands of light that has been diffracted by natural or artificial processes. The data are combined and analyzed using the standard techniques of very long baseline interferometry. This method is useful for providing on the order of a half minute of extra data from the past for distant astronomical events. The method is also useful for providing on the order of tenths of microseconds of extra data from the past for electric meteorological events.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: December 8, 1998
    Inventor: Allen D. Allen
  • Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
    Patent number: 5651970
    Abstract: Methods for treating and inhibiting disease and symptoms associated with the human immunodeficiency virus (HIV) are provided. The method includes transforming the human immunodeficiency virus (HIV) infection into a nonserious disease through the infusion of monoclonal antibodies directed against particular antigens on anti-self, anti-CD4 cytotoxic T-lymphocytes.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 29, 1997
    Inventor: Allen D. Allen
  • Method for increasing CD4+ cell numbers through the use of monoclonal antibodies directed against self-reactive, CD4 specific cytotoxic T-cells
    Patent number: 5424066
    Abstract: A method of increasing the number of CD4+ cells in patients infected with the human immunodeficency virus is provided. The method includes injecting monoclonal antibodies directed against particular antigens on self-reactive, CD4 specific cytotoxic T-cells.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: June 13, 1995
    Inventor: Allen D. Allen
  • Method for the effective treatment of disease conditions in humans associated with HTLV-III infection
    Patent number: 5019557
    Abstract: A method for the treatment of human disease conditions associated with HTLV infection is disclosed which is effective both as a treatment for HTLV infected individuals as well as a prophylactic treatment. The method comprises the step of hyperimmunizing a human patient with polio virus through the repeated administration of an effective dosage of polio vaccine until an effective immune response is obtained.
    Type: Grant
    Filed: July 10, 1989
    Date of Patent: May 28, 1991
    Inventors: Ferris N. Pitts, Jr., Allen D. Allen